234 related articles for article (PubMed ID: 33822434)
1. Reduction in miR-219 expression underlies cellular pathogenesis of oligodendrocytes in a mouse model of Krabbe disease.
Inamura N; Go S; Watanabe T; Takase H; Takakura N; Nakayama A; Takebayashi H; Matsuda J; Enokido Y
Brain Pathol; 2021 Sep; 31(5):e12951. PubMed ID: 33822434
[TBL] [Abstract][Full Text] [Related]
2. Developmental defects and aberrant accumulation of endogenous psychosine in oligodendrocytes in a murine model of Krabbe disease.
Inamura N; Kito M; Go S; Kishi S; Hosokawa M; Asai K; Takakura N; Takebayashi H; Matsuda J; Enokido Y
Neurobiol Dis; 2018 Dec; 120():51-62. PubMed ID: 30176352
[TBL] [Abstract][Full Text] [Related]
3. Krabbe disease: involvement of connexin43 in the apoptotic effects of sphingolipid psychosine on mouse oligodendrocyte precursors.
Graziano AC; Parenti R; Avola R; Cardile V
Apoptosis; 2016 Jan; 21(1):25-35. PubMed ID: 26459425
[TBL] [Abstract][Full Text] [Related]
4. Promyelinating drugs ameliorate oligodendrocyte pathologies in a mouse model of Krabbe disease.
Inamura N; Kawai T; Watanabe T; Aoki H; Aoyama M; Nakayama A; Matsuda J; Enokido Y
Mol Genet Metab; 2024 May; 142(3):108497. PubMed ID: 38763041
[TBL] [Abstract][Full Text] [Related]
5. Galactosylceramidase deficiency and pathological abnormalities in cerebral white matter of Krabbe disease.
Iacono D; Koga S; Peng H; Manavalan A; Daiker J; Castanedes-Casey M; Martin NB; Herdt AR; Gelb MH; Dickson DW; Lee CW
Neurobiol Dis; 2022 Nov; 174():105862. PubMed ID: 36113749
[TBL] [Abstract][Full Text] [Related]
6. Krabbe disease: psychosine-mediated activation of phospholipase A2 in oligodendrocyte cell death.
Giri S; Khan M; Rattan R; Singh I; Singh AK
J Lipid Res; 2006 Jul; 47(7):1478-92. PubMed ID: 16645197
[TBL] [Abstract][Full Text] [Related]
7. Role of endogenous psychosine accumulation in oligodendrocyte differentiation and survival: implication for Krabbe disease.
Won JS; Kim J; Paintlia MK; Singh I; Singh AK
Brain Res; 2013 May; 1508():44-52. PubMed ID: 23438514
[TBL] [Abstract][Full Text] [Related]
8. Genetic ablation of Saposin-D in Krabbe disease eliminates psychosine accumulation but does not significantly improve demyelination.
Watanabe T; Tsuboi K; Matsuda N; Ishizuka Y; Go S; Watanabe E; Ono A; Okamoto Y; Matsuda J
J Neurochem; 2023 Aug; 166(4):720-746. PubMed ID: 37337846
[TBL] [Abstract][Full Text] [Related]
9. Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease.
Ribbens JJ; Moser AB; Hubbard WC; Bongarzone ER; Maegawa GH
Mol Genet Metab; 2014 Feb; 111(2):172-83. PubMed ID: 24094551
[TBL] [Abstract][Full Text] [Related]
10. Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target.
Li Y; Xu Y; Benitez BA; Nagree MS; Dearborn JT; Jiang X; Guzman MA; Woloszynek JC; Giaramita A; Yip BK; Elsbernd J; Babcock MC; Lo M; Fowler SC; Wozniak DF; Vogler CA; Medin JA; Crawford BE; Sands MS
Proc Natl Acad Sci U S A; 2019 Oct; 116(40):20097-20103. PubMed ID: 31527255
[TBL] [Abstract][Full Text] [Related]
11. A galactose-free diet enriched in soy isoflavones and antioxidants results in delayed onset of symptoms of Krabbe disease in twitcher mice.
Pannuzzo G; Cardile V; Costantino-Ceccarini E; Alvares E; Mazzone D; Perciavalle V
Mol Genet Metab; 2010 Jul; 100(3):234-40. PubMed ID: 20418135
[TBL] [Abstract][Full Text] [Related]
12. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
[TBL] [Abstract][Full Text] [Related]
13. Effect of vitamin D3 intake on the onset of disease in a murine model of human Krabbe disease.
Paintlia MK; Singh I; Singh AK
J Neurosci Res; 2015 Jan; 93(1):28-42. PubMed ID: 25236689
[TBL] [Abstract][Full Text] [Related]
14. Perineuronal oligodendrocytes protect against neuronal apoptosis through the production of lipocalin-type prostaglandin D synthase in a genetic demyelinating model.
Taniike M; Mohri I; Eguchi N; Beuckmann CT; Suzuki K; Urade Y
J Neurosci; 2002 Jun; 22(12):4885-96. PubMed ID: 12077186
[TBL] [Abstract][Full Text] [Related]
15. Galactosylceramidase deficiency causes sperm abnormalities in the mouse model of globoid cell leukodystrophy.
Luddi A; Strazza M; Carbone M; Moretti E; Costantino-Ceccarini E
Exp Cell Res; 2005 Mar; 304(1):59-68. PubMed ID: 15707574
[TBL] [Abstract][Full Text] [Related]
16. Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
Hawkins-Salsbury JA; Shea L; Jiang X; Hunter DA; Guzman AM; Reddy AS; Qin EY; Li Y; Gray SJ; Ory DS; Sands MS
J Neurosci; 2015 Apr; 35(16):6495-505. PubMed ID: 25904800
[TBL] [Abstract][Full Text] [Related]
17. Visual System Impairment in a Mouse Model of Krabbe Disease: The Twitcher Mouse.
Tonazzini I; Cerri C; Del Grosso A; Antonini S; Allegra M; Caleo M; Cecchini M
Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33374753
[TBL] [Abstract][Full Text] [Related]
18. Generation of a LacZ reporter transgenic mouse line for the stereological analysis of oligodendrocyte loss in galactosylceramidase deficiency.
Zhu H; Ornaghi F; Belin S; Givogri MI; Wrabetz L; Bongarzone ER
J Neurosci Res; 2016 Dec; 94(12):1520-1530. PubMed ID: 27426866
[TBL] [Abstract][Full Text] [Related]
19. Central nervous system pathology progresses independently of KC and CXCR2 in globoid-cell leukodystrophy.
Reddy AS; Patel JR; Vogler C; Klein RS; Sands MS
PLoS One; 2014; 8(6):e64647. PubMed ID: 23755134
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic cell transplantation in murine globoid cell leukodystrophy (the twitcher mouse): effects on levels of galactosylceramidase, psychosine, and galactocerebrosides.
Ichioka T; Kishimoto Y; Brennan S; Santos GW; Yeager AM
Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4259-63. PubMed ID: 2884662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
